1. Home
  2. GNFT vs VBF Comparison

GNFT vs VBF Comparison

Compare GNFT & VBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • VBF
  • Stock Information
  • Founded
  • GNFT 1999
  • VBF 1970
  • Country
  • GNFT France
  • VBF United States
  • Employees
  • GNFT N/A
  • VBF N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • VBF Trusts Except Educational Religious and Charitable
  • Sector
  • GNFT Health Care
  • VBF Finance
  • Exchange
  • GNFT Nasdaq
  • VBF Nasdaq
  • Market Cap
  • GNFT 202.6M
  • VBF 177.3M
  • IPO Year
  • GNFT 2019
  • VBF N/A
  • Fundamental
  • Price
  • GNFT $3.83
  • VBF $15.52
  • Analyst Decision
  • GNFT Strong Buy
  • VBF
  • Analyst Count
  • GNFT 1
  • VBF 0
  • Target Price
  • GNFT $13.00
  • VBF N/A
  • AVG Volume (30 Days)
  • GNFT 12.6K
  • VBF 45.5K
  • Earning Date
  • GNFT 04-03-2025
  • VBF 01-01-0001
  • Dividend Yield
  • GNFT N/A
  • VBF 5.18%
  • EPS Growth
  • GNFT N/A
  • VBF N/A
  • EPS
  • GNFT 0.47
  • VBF N/A
  • Revenue
  • GNFT $86,225,222.00
  • VBF N/A
  • Revenue This Year
  • GNFT $145.20
  • VBF N/A
  • Revenue Next Year
  • GNFT N/A
  • VBF N/A
  • P/E Ratio
  • GNFT $7.98
  • VBF N/A
  • Revenue Growth
  • GNFT 175.45
  • VBF N/A
  • 52 Week Low
  • GNFT $3.35
  • VBF $13.68
  • 52 Week High
  • GNFT $6.42
  • VBF $16.27
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 48.44
  • VBF 44.49
  • Support Level
  • GNFT $3.69
  • VBF $15.42
  • Resistance Level
  • GNFT $4.03
  • VBF $15.65
  • Average True Range (ATR)
  • GNFT 0.16
  • VBF 0.14
  • MACD
  • GNFT -0.00
  • VBF -0.02
  • Stochastic Oscillator
  • GNFT 24.59
  • VBF 14.93

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About VBF Invesco Bond Fund

Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.

Share on Social Networks: